arm sagging post-glp-1 weight drop causes In early 2025, the AAFPRS reported that "Ozempic face," the skin, wrinkles and hollowed cheeks associated with GLP-1-related loss, had led to an increase in fat grafting procedures and other Just started your GLP-1 journey?

The interaction between growth hormone pathway activation and triple-receptor incretin agonism creates metabolic variables that must be tracked consistently

Physical activity integration should be practical and sustainable

This can lead to daytime fatigue, headaches and other short-term symptoms, as well as an increased risk of cardiovascular disease, diabetes and mental health changes

Important considerations before combining these medications include: Absolute contraindications : The combination should be avoided in patients with cardiovascular disease, uncontrolled hypertension, hyperthyroidism, glaucoma, during or within 14 days of MAOI use, personal/family history of MTC or MEN2, pregnancy, breastfeeding, or severe gastrointestinal disease Cardiovascular risk assessment : Phentermine increases heart rate and blood pressure, which requires careful monitoring with baseline and follow-up measurements of vital signs and possibly EKG if cardiac history exists Gastrointestinal tolerability : Tirzepatide commonly causes nausea, vomiting, and diarrhea, which may be compounded by phentermine's effects Medication interactions : Tirzepatide may reduce the effectiveness of oral contraceptives during initiation and dose escalation

Side Effects and Safety Considerations Both sermorelin and BPC-157 should be used under medical supervision

They include: Tackling Free Radicals and Oxidative Stress